Taxifolin | CAS:480-18-2

We serve Taxifolin CAS:480-18-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Taxifolin

Synonyms：
(3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-chromen-4-one
4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R-trans)-
(2R,3R)-3,3',4',5,7-Pentahydroxyflavanone

 
Molecular Formula: C15H12O7
Molecular weight：304.25200
 
Appearance and properties: light yellow powder
Density: 1.702 g/cm3
Boiling point: 687.6ºC
Melting point: 230-233°C (dec.)
Flash point: 264.2ºC
Refractive index: 1.762
 
Storage conditions: -20ºC Freezer
Vapor pressure: 7.51E-20mmHg at 25°C
Uses: It can inhibit the growth of ovarian cancer cells in a dose-dependent manner. Compared with Qercetin, Douglas fir is not mutagenic and has low toxicity. Douglas fir regulates genes through an ARE-dependent mechanism to play a potential chemopreventive effect.

 
 
Items of Analysis Standard of Analysis Test Results
Appearance Light yellow powder Conform
Loss on drying ≤5.0% 0.89%
Ash ≤5.0% 0.10%
Heavy metals Pb ≤0.5ppm Conform
As ≤0.3ppm Conform
Cd ≤0.5ppm Conform
Hg ≤0.1ppm Conform
Microbiological Total Plate Count ≤1000CFU/g Conform
Yeast & Mold ≤100CFU/g Conform
E. Coli ≤3MPN/g ND
Control bacteria /25g Negative ND
Purity (HPLC) ≥98.0% 98.5%
Conclusion Conforms to Factory Standard
 




Contact us for information like Taxifolin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R,3R)-3,3′,4′,5,7-Pentahydroxyflavanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Taxifolin Use and application,Taxifolin technical grade,usp/ep/jp grade.


Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-ribofuranosyl)-uracil manufacturer Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.(Z)-5-dimethylphenylsilyl-5-trimethylsilyl-4-penten-1-ol supplier Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.butan-2-one-(2-bromo-5-nitro-phenylhydrazone) vendor Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.